Purchase Order HHSN269201600604P
Award Date 7/11/16
Potential Completion Date 7/10/17
Potential Value $226K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, by the National Institutes of Health (NIH) Clinical Center. The contract, valued at $56,760.00, is for the purchase of various medical supplies and equipment related to blood collection, separation, storage, and transfusion. The contract includes items such as blood collection assemblies, washing solutions, diluting solutions, anticoagulant citrate products, donor tubing...
- The National Institutes of Health Clinical Center awarded a purchase order to Fenwal, Inc. valued at $46,200.00 on July 1, 2017, for blood collection, separation, storage, and transfusion products and related medical consumables. Place of performance is Bethesda, Maryland. The order carries firm fixed-price pricing with no set-aside designation. Ultimate completion was scheduled for June 30, 2018. Fenwal is a blood technology manufacturer specializing in collection assemblies, anticoagulant...
- The U.S. National Institutes of Health (NIH) awarded a $17,058.37 firm-fixed-price purchase order contract to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract, which does not have a set-aside designation, is for the provision of medical supplies and equipment to support transfusion medicine and cell therapy applications, including blood bags, tubing, solutions, apheresis equipment, and other specialized items. Fenwal has a long history of providing a...
- This firm-fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Fenwal, Inc., a Fresenius Kabi company, for the supply of specialized blood collection, separation, storage, and transfusion products and services. The $1,176.75 contract will support the U.S. military's frozen blood program and provide consumables, cell processing kits, separators, and service agreements to facilitate biomedical research and blood banking operations for the federal government. Fenwal, a...
- The Defense Logistics Agency Troop Support Medical has awarded Fenwal, Inc., a Fresenius Kabi company, a $1,062.50 firm-fixed-price purchase order for blood collection products and services. Fenwal, a global blood technology company, will provide items such as blood bags, tubing, solutions, and equipment to support the U.S. military's blood program and federal biomedical research. This contract was awarded without a set-aside designation due to Fenwal's specialized capabilities as a manufacturer...
- The NIH Clinical Center awarded a purchase order to Fenwal, Inc. valued at $13,000 on June 20, 2017, for blood technology products and services. Performance was to occur in Bethesda, Maryland, with an ultimate completion date of July 31, 2018. The order was issued on a firm fixed-price basis without set-aside designation. Fenwal, a specialist in blood collection, separation, storage, and transfusion products, supplied blood banking consumables and equipment to support the Clinical Center's...
- This federal contract award, valued at $1,062.50, was issued by the Defense Logistics Agency Troop Support Medical to Fenwal, Inc., a subsidiary of Fresenius Kabi. The contract is for the supply of various blood collection and processing products, including blood bags, tubing, solutions, and apheresis equipment, to support transfusion medicine and cell therapy applications for federal agencies such as the Department of Defense, Department of Veterans Affairs, and National Institutes of Health....
- This purchase order, valued at $13,000, was awarded to Fenwal, Inc. on March 25, 2010, for service contract support of AMICUS-B1 apheresis machines (Serial #D0904M4055 and D0904M4062) at the National Institutes of Health Clinical Center in Bethesda, Maryland. The contract, which was funded through the Office of the Chief Operating Officer and had an ultimate completion date of May 4, 2011, was awarded without set-aside designation, reflecting Fenwal's specialized capabilities in apheresis...
- <p>The NIH Clinical Center awarded a firm fixed-price purchase order to Fenwal, Inc. valued at $75,000 on May 8, 2018, with a completion date of June 8, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. Fenwal supplies blood collection, separation, storage, and transfusion products and related equipment to federal health agencies. The order carries firm fixed-price pricing with no small business designation.</p>
- This is a federal purchase order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Fenwal, Inc., a subsidiary of Fresenius Kabi, for the supply of various blood collection and transfusion-related products and services. The contract, valued at $4,594.60, has an ultimate completion date of October 22, 2024. Fenwal, a global blood technology company, has been a registered vendor with the U.S. federal government since 2007 and has established itself as a key supplier to...